Detailed Mechanism Funding and Narrative

Years of mechanism: 2017 2018 2019 2020

Details for Mechanism ID: 18544
Country/Region: Malawi
Year: 2017
Main Partner: Elizabeth Glaser Pediatric AIDS Foundation
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $10,081,525 Additional Pipeline Funding: $100,000

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $201,630
Care: TB/HIV (HVTB) $604,891
Care: Pediatric Care and Support (PDCS) $504,076
Sexual Prevention: Abstinence/Be Faithful (HVAB) $98,849
Testing: HIV Testing and Counseling (HVCT) $175,109
Sexual Prevention: Other Sexual Prevention (HVOP) $150,115
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $403,261
Treatment: Adult Treatment (HTXS) $7,641,148
Treatment: Pediatric Treatment (PDTX) $302,446
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 964,577
HTS_TST Service Delivery Point (Facility) ANC: 10-14, Negative 2018 406
HTS_TST Service Delivery Point (Facility) ANC: 15-19, Negative 2018 27,437
HTS_TST Service Delivery Point (Facility) ANC: 20-24, Negative 2018 41,542
HTS_TST Service Delivery Point (Facility) ANC: 25-49, Negative 2018 54,321
HTS_TST Service Delivery Point (Facility) ANC: 50+, Negative 2018 276
HTS_TST Service Delivery Point (Facility) Index: <1, Negative 2018 2,902
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2018 23,181
HTS_TST Service Delivery Point (Facility) Index: 10-14, Female, Negative 2018 5,049
HTS_TST Service Delivery Point (Facility) Index: 10-14, Male, Negative 2018 4,902
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2018 7,920
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2018 8,186
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2018 7,920
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2018 8,186
HTS_TST Service Delivery Point (Facility) Index: 25-49, Female, Negative 2018 29,723
HTS_TST Service Delivery Point (Facility) Index: 25-49, Male, Negative 2018 47,196
HTS_TST Service Delivery Point (Facility) Index: 50+, Female, Negative 2018 297
HTS_TST Service Delivery Point (Facility) Inpatient: <1, Negative 2018 1,952
HTS_TST Service Delivery Point (Facility) Inpatient: 1-9, Negative 2018 15,592
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2018 3,400
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2018 3,291
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2018 2,231
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2018 2,788
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2018 2,231
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2018 2,788
HTS_TST Service Delivery Point (Facility) Inpatient: 25-49, Female, Negative 2018 6,694
HTS_TST Service Delivery Point (Facility) Inpatient: 25-49, Male, Negative 2018 10,121
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2018 53
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2018 526
HTS_TST Service Delivery Point (Facility) Other PITC: 1-9, Negative 2018 1,547
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2018 336
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2018 321
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2018 2,858
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2018 12,430
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2018 2,858
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2018 12,430
HTS_TST Service Delivery Point (Facility) Other PITC: 25-49, Female, Negative 2018 7,459
HTS_TST Service Delivery Point (Facility) Other PITC: 25-49, Male, Negative 2018 20,842
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2018 66
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2018 1,097
HTS_TST Service Delivery Point (Facility) TB: <1, Negative 2018 63
HTS_TST Service Delivery Point (Facility) TB: 1-9, Negative 2018 565
HTS_TST Service Delivery Point (Facility) TB: 10-14, Female, Negative 2018 113
HTS_TST Service Delivery Point (Facility) TB: 10-14, Male, Negative 2018 107
HTS_TST Service Delivery Point (Facility) TB: 15-19, Female, Negative 2018 946
HTS_TST Service Delivery Point (Facility) TB: 15-19, Male, Negative 2018 2,403
HTS_TST Service Delivery Point (Facility) TB: 20-24, Female, Negative 2018 946
HTS_TST Service Delivery Point (Facility) TB: 20-24, Male, Negative 2018 2,403
HTS_TST Service Delivery Point (Facility) TB: 25-49, Female, Negative 2018 4,717
HTS_TST Service Delivery Point (Facility) TB: 25-49, Male, Negative 2018 11,182
HTS_TST Service Delivery Point (Facility) TB: 50+, Female, Negative 2018 38
HTS_TST Service Delivery Point (Facility) TB: 50+, Male, Negative 2018 583
HTS_TST Service Delivery Point (Facility) VCT: <1, Negative 2018 222
HTS_TST Service Delivery Point (Facility) VCT: 1-9, Negative 2018 1,801
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Female, Negative 2018 393
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Male, Negative 2018 377
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Female, Negative 2018 38,963
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Male, Negative 2018 55,671
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Female, Negative 2018 38,963
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Male, Negative 2018 55,671
HTS_TST Service Delivery Point (Facility) VCT: 25-49, Female, Negative 2018 93,311
HTS_TST Service Delivery Point (Facility) VCT: 25-49, Male, Negative 2018 190,246
HTS_TST Service Delivery Point (Facility) VCT: 50+, Female, Negative 2018 945
HTS_TST Service Delivery Point (Facility) VCT: 50+, Male, Negative 2018 10,010
HTS_TST Service Delivery Point (Facility) VMMC: 15-19, Negative 2018 1,282
HTS_TST Service Delivery Point (Facility) VMMC: 20-24, Negative 2018 1,282
HTS_TST Service Delivery Point (Facility) VMMC: 25-49, Negative 2018 13,406
HTS_TST Service Delivery Point (Facility) VMMC: 50+, Negative 2018 711
HTS_TST Service Delivery Point (Facility)Other PITC: <1, Negative 2018 196
HTS_TST Service Delivery Point by Agg Age (Community) Other: <15, Female, Negative 2018 83
HTS_TST Service Delivery Point by Agg Age (Community) Other: <15, Male, Negative 2018 83
HTS_TST Service Delivery Point by Agg Age (Community) Other: 15+, Female, Negative 2018 90
HTS_TST Service Delivery Point by Agg Age (Community) Other: 15+, Male, Negative 2018 1,755
HTS_TST Sum of Test Result disaggregates 2018 52,215
HTS_TST_POS By Test Result: Positive 2018 52,215
HTS_TST_POS Service Delivery Point (Facility) ANC: 15-19, Positive 2018 547
HTS_TST_POS Service Delivery Point (Facility) ANC: 20-24, Positive 2018 1,526
HTS_TST_POS Service Delivery Point (Facility) ANC: 25-49, Positive 2018 3,369
HTS_TST_POS Service Delivery Point (Facility) Index: <1, Positive 2018 138
HTS_TST_POS Service Delivery Point (Facility) Index: 1-9, Positive 2018 1,173
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Female, Positive 2018 253
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Male, Positive 2018 243
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2018 558
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Male, Positive 2018 538
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Female, Positive 2018 558
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Male, Positive 2018 538
HTS_TST_POS Service Delivery Point (Facility) Index: 25-49, Female, Positive 2018 2,249
HTS_TST_POS Service Delivery Point (Facility) Index: 25-49, Male, Positive 2018 3,269
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Female, Positive 2018 14
HTS_TST_POS Service Delivery Point (Facility) Inpatient: <1, Positive 2018 115
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 1-9, Positive 2018 1,057
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Female, Positive 2018 220
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Male, Positive 2018 217
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2018 133
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2018 177
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2018 133
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2018 177
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 25-49, Female, Positive 2018 471
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 25-49, Male, Positive 2018 660
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Male, Positive 2018 26
HTS_TST_POS Service Delivery Point (Facility) Other PITC: <1, Positive 2018 4
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 1-9, Positive 2018 75
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2018 13
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Male, Positive 2018 13
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2018 162
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2018 718
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2018 162
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2018 718
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 25-49, Female, Positive 2018 465
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 25-49, Male, Positive 2018 1,200
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2018 46
HTS_TST_POS Service Delivery Point (Facility) TB: <1, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) TB: 1-9, Positive 2018 35
HTS_TST_POS Service Delivery Point (Facility) TB: 10-14, Female, Positive 2018 6
HTS_TST_POS Service Delivery Point (Facility) TB: 10-14, Male, Positive 2018 5
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Female, Positive 2018 66
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Male, Positive 2018 172
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Female, Positive 2018 66
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Male, Positive 2018 172
HTS_TST_POS Service Delivery Point (Facility) TB: 25-49, Female, Positive 2018 365
HTS_TST_POS Service Delivery Point (Facility) TB: 25-49, Male, Positive 2018 830
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Male, Positive 2018 34
HTS_TST_POS Service Delivery Point (Facility) VCT: <1, Positive 2018 5
HTS_TST_POS Service Delivery Point (Facility) VCT: 1-9, Positive 2018 88
HTS_TST_POS Service Delivery Point (Facility) VCT: 10-14, Female, Positive 2018 13
HTS_TST_POS Service Delivery Point (Facility) VCT: 10-14, Male, Positive 2018 13
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Female, Positive 2018 2,165
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Male, Positive 2018 2,896
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Female, Positive 2018 2,165
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Male, Positive 2018 2,896
HTS_TST_POS Service Delivery Point (Facility) VCT: 25-49, Female, Positive 2018 5,451
HTS_TST_POS Service Delivery Point (Facility) VCT: 25-49, Male, Positive 2018 10,008
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Female, Positive 2018 39
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Male, Positive 2018 524
HTS_TST_POS Service Delivery Point (Facility) VMMC: 15-19, Positive 2018 15
HTS_TST_POS Service Delivery Point (Facility) VMMC: 20-24, Positive 2018 15
HTS_TST_POS Service Delivery Point (Facility) VMMC: 25-49, Positive 2018 147
HTS_TST_POS Service Delivery Point by Agg Age (Community) Other: 15+, Male, Positive 2018 1,539
PMTCT_ART Already on ART at beginning of current pregnancy 2018 6,250
PMTCT_ART New on ART 2018 5,761
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 12,011
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 136,708
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 12,013
PMTCT_EID Number of infants with a negative virological test result between 2 and 12 months of birth 2018 6,674
PMTCT_EID Number of infants with a negative virological test result within 2 months of birth 2018 5,159
PMTCT_EID Number of infants with a positive virological test result between 2 and 12 months of birth 2018 110
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2018 70
PMTCT_STAT By Age (Numerator): 10-14 2018 406
PMTCT_STAT By Age (Numerator): 15-19 2018 28,709
PMTCT_STAT By Age (Numerator): 20-24 2018 45,117
PMTCT_STAT By Age (Numerator): 25-49 2018 62,200
PMTCT_STAT By Age (Numerator): 50+ 2018 276
PMTCT_STAT By Number of known positives: 15-19 2018 727
PMTCT_STAT By Number of known positives: 20-24 2018 2,040
PMTCT_STAT By Number of known positives: 25-49 2018 4,515
PMTCT_STAT By Number of new negative: 10-14 2018 406
PMTCT_STAT By Number of new negative: 15-19 2018 27,437
PMTCT_STAT By Number of new negative: 20-24 2018 41,542
PMTCT_STAT By Number of new negative: 25-49 2018 54,320
PMTCT_STAT By Number of new negative: 50+ 2018 276
PMTCT_STAT By Number of new positives: 15-19 2018 547
PMTCT_STAT By Number of new positives: 20-24 2018 1,526
PMTCT_STAT By Number of new positives: 25-49 2018 3,372
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 136,708
PMTCT_STAT_den By Age (Denominator): <15-19 2018 30,220
PMTCT_STAT_den By Age (Denominator): 10-14 2018 433
PMTCT_STAT_den By Age (Denominator): 20-24 2018 47,487
PMTCT_STAT_den By Age (Denominator): 25-49 2018 65,473
PMTCT_STAT_den By Age (Denominator): 50+ 2018 288
PP_PREV Age/sex: 15-19 Female 2018 56
PP_PREV Age/sex: 20-24 Female 2018 32
PP_PREV Age/sex: 20-24 Male 2018 212
PP_PREV Age/sex: 25-49 Female 2018 116
PP_PREV Age/sex: 25-49 Male 2018 132
PP_PREV Age/sex: 50+ Female 2018 35
PP_PREV Age/sex: 50+ Male 2018 17
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2018 600
PP_PREV Sum of Age/Sex disaggregates 2018 600
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 113
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 113
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 1,424
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 669
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 2,405
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 2,319
TB_ART_den Aggregated Age/Sex: Female <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 117
TB_ART_den Aggregated Age/Sex: Female 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 117
TB_ART_den Aggregated Age/Sex: Male <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 1,475
TB_ART_den Aggregated Age/Sex: Male 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 696
TB_PREV By Age/Sex (Numerator): <15, Female 2018 3,451
TB_PREV By Age/Sex (Numerator): <15, Male 2018 3,231
TB_PREV By Age/Sex (Numerator): 15+, Female 2018 43,276
TB_PREV By Age/Sex (Numerator): 15+, Male 2018 24,010
TB_PREV By Therapy type (Numerator): Continuous IPT 2018 73,968
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2018 73,968
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2018 76,238
TB_PREV_den By Age/Sex (Denominator): <15, Female 2018 3,561
TB_PREV_den By Age/Sex (Denominator): <15, Male 2018 3,333
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2018 44,597
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2018 24,747
TB_PREV_den By Therapy type (Denominator): Continuous IPT 2018 76,238
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 198
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 1,174
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 198
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 2,454
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 4,024
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2018 4,194
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 210
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 1,211
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 210
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 2,563
TX_CURR Age/Sex: <1 2018 3,239
TX_CURR Age/Sex: <1-9 2018 13,816
TX_CURR Age/Sex: 10-14 Female 2018 2,008
TX_CURR Age/Sex: 10-14 Male 2018 1,939
TX_CURR Age/Sex: 15-19 Female 2018 7,014
TX_CURR Age/Sex: 15-19 Male 2018 4,042
TX_CURR Age/Sex: 20-24 Female 2018 8,859
TX_CURR Age/Sex: 20-24 Male 2018 4,042
TX_CURR Age/Sex: 25-49 Female 2018 120,139
TX_CURR Age/Sex: 25-49 Male 2018 78,904
TX_CURR Age/Sex: 50+ Female 2018 925
TX_CURR Age/Sex: 50+ Male 2018 4,152
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 249,079
TX_CURR Sum of age/sex disaggregates 2018 11,056
TX_NEW Breastfeeding status 2018 3,765
TX_NEW By Age/Sex: <1 2018 172
TX_NEW By Age/Sex: 1-9 2018 3,416
TX_NEW By Age/Sex: 10-14 Female 2018 477
TX_NEW By Age/Sex: 10-14 Male 2018 437
TX_NEW By Age/Sex: 15-19 Female 2018 4,632
TX_NEW By Age/Sex: 15-19 Male 2018 7,554
TX_NEW By Age/Sex: 20-24 Female 2018 5,642
TX_NEW By Age/Sex: 20-24 Male 2018 7,554
TX_NEW By Age/Sex: 25-49 Female 2018 13,021
TX_NEW By Age/Sex: 25-49 Male 2018 21,384
TX_NEW By Age/Sex: 50+ Female 2018 98
TX_NEW By Age/Sex: 50+ Male 2018 1,117
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 65,504
TX_NEW Pregnancy status 2018 13,914
TX_NEW Sum of Age/Sex disaggregates 2018 61,916
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 136,855
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 123,175
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 3,589
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 89
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 3,589
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 89
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 72,940
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 2,190
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 39,468
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 1,221
TX_PVLS Numerator: Indication: Routine 2018 119,586
TX_PVLS Numerator: Indication: Targeted 2018 3,589
TX_PVLS Numerator: Preg/BF by Indication: Breastfeeding Routine 2018 15,184
TX_PVLS Numerator: Preg/BF by Indication: Breastfeeding Targeted 2018 451
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Routine 2018 15,184
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Targeted 2018 451
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 3,993
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 102
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 3,993
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 102
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 81,055
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 2,424
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 43,821
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 1,365
TX_PVLS_den Denominator: Indication: Routine 2018 132,862
TX_PVLS_den Denominator: Indication: Targeted 2018 3,993
TX_PVLS_den Denominator: Preg/BF by Indication: Breastfeeding Routine 2018 16,867
TX_PVLS_den Denominator: Preg/BF by Indication: Breastfeeding Targeted 2018 505
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Routine 2018 16,867
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Targeted 2018 505
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 1,122
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 1,122
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 19,312
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 9,813
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 31,369
TX_RET Numerator by Status: Breastfeeding 2018 936
TX_RET Numerator by Status: Pregnant 2018 506
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 41,801
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 1,674
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 1,674
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 25,497
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 12,956
TX_RET_den Denominator by Status: Breastfeeding 2018 1,172
TX_RET_den Denominator by Status: Pregnant 2018 629
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2018 223,519
TX_TB Number of ART patients who were started on TB treatment during the reporting period 2018 2,282
TX_TB Numerator: By Aggregated Age/Sex: <15, Female 2018 102
TX_TB Numerator: By Aggregated Age/Sex: <15, Male 2018 102
TX_TB Numerator: By Aggregated Age/Sex: 15+, Female 2018 1,352
TX_TB Numerator: By Aggregated Age/Sex: 15+, Male 2018 726
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2018 11,169
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2018 11,169
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2018 129,655
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2018 71,526
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2018 1,752
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Other (No Xpert) 2018 71
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2018 6,878
TX_TB_den Denominator: By Screen Result: Negative 2018 210,276
TX_TB_den Denominator: By Screen Result: Positive 2018 8,538
TX_TB_den Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2018 8,538
Cross Cutting Budget Categories and Known Amounts Total: $933,400
Key Populations: Sex Workers $9,200
Training of health workers and community outreach workers
Key Populations: MSM and TG $9,200
Water $100,000
Renovation $150,000
Human Resources for Health $150,000
Motor Vehicles: Purchased $515,000